Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
International Seaways
INSW
$4.91B
| $661K | ﹤0.01% |
39,255
-4,939
| -11% | -$95.3K |
|
2777
Expeditors International
EXPD
$24.6B
| $660K | ﹤0.01% |
+9,694
| New | +$681K |
|
2778
Qfin Holdings
QFIN
$1.4B
| $659K | ﹤0.01% |
+42,721
| New | +$681K |
|
2779
TC Energy
TRP
$64.4B
| $657K | ﹤0.01% |
18,401
-182,027
| -91% | -$7.18M |
|
|
XONE
2780
DELISTED
The ExOne Company
XONE
| $656K | ﹤0.01% |
99,031
+62,894
| +174% | +$506K |
|
2781
Antero Midstream
AM
$10.4B
| $653K | ﹤0.01% |
58,451
-594,239
| -91% | -$9.07M |
|
2782
Hawkins
HWKN
$2.47B
| $651K | ﹤0.01% |
31,804
-78,568
| -71% | -$1.53M |
|
2783
NI Holdings
NODK
$313M
| $651K | ﹤0.01% |
+41,384
| New | +$659K |
|
2784
Invesco Senior Loan ETF
BKLN
$6.78B
| $649K | ﹤0.01% |
29,800
+15,370
| +107% | +$350K |
|
|
BGB
2785
Blackstone Strategic Credit 2027 Term Fund
BGB
$501M
| $648K | ﹤0.01% |
+48,122
| New | +$712K |
|
|
HA
2786
DELISTED
Hawaiian Holdings, Inc.
HA
| $645K | ﹤0.01% |
24,415
+5,828
| +31% | +$197K |
|
2787
MYR Group
MYRG
$4.61B
| $642K | ﹤0.01% |
22,797
+6,257
| +38% | +$194K |
|
2788
Columbia Banking Systems
COLB
$8.64B
| $639K | ﹤0.01% |
17,608
-27,181
| -61% | -$1.02M |
|
2789
Under Armour Class C
UA
$2.15B
| $638K | ﹤0.01% |
+39,428
| New | +$746K |
|
2790
J&J Snack Foods
JJSF
$1.67B
| $637K | ﹤0.01% |
+4,408
| New | +$670K |
|
2791
Viking Therapeutics
VKTX
$3.99B
| $634K | ﹤0.01% |
82,900
-286,516
| -78% | -$3.43M |
|
|
EIGI
2792
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $634K | ﹤0.01% |
95,357
-293,835
| -75% | -$2.44M |
|
|
HMTA
2793
DELISTED
HomeTown Bankshares Corporation Common Stock
HMTA
| $633K | ﹤0.01% |
53,447
-13,685
| -20% | -$194K |
|
2794
Lexicon Pharmaceuticals
LXRX
$1.04B
| $632K | ﹤0.01% |
95,169
+11,862
| +14% | +$96.1K |
|
2795
Maximus
MMS
$3.06B
| $632K | ﹤0.01% |
9,717
-22,532
| -70% | -$1.48M |
|
|
GEN
2796
DELISTED
Genesis Healthcare, Inc.
GEN
| $632K | ﹤0.01% |
535,970
+237,370
| +79% | +$352K |
|
|
BRKL
2797
DELISTED
Brookline Bancorp
BRKL
| $629K | ﹤0.01% |
+45,516
| New | +$687K |
|
2798
Core Molding Technologies
CMT
$224M
| $629K | ﹤0.01% |
88,447
-18,557
| -17% | -$134K |
|
2799
CALL
Norfolk Southern
NSC
$78.9B
| $628K | ﹤0.01% |
4,200
-47,200
| -92% | -$7.76M |
|
2800
Nelnet
NNI
$4.61B
| $627K | ﹤0.01% |
+11,981
| New | +$645K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.